Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer-Reference-Cited by-同舟云学术

Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer

Published:2017-09-26 Issue:3 Volume:110 Page:250-257
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Saintigny Pierre¹²,William William N³,Foy Jean-Philippe¹²,Papadimitrakopoulou Vassiliki³,Lang Wenhua³,Zhang Li⁴,Fan You Hong³,Feng Lei⁵,Kim Edward S⁶,El-Naggar Adel K⁵,Lee J Jack⁵,Mao Li⁷,Hong Waun Ki⁸,Lingen Mark W⁹,Lippman Scott M¹⁰

Affiliation:

1. Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France

2. Department of Medicine, Centre Léon Bérard, Lyon, France, Université Lyon 1, Lyon, France

3. Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

4. Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

5. Biostatistics, Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

6. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

7. Oncology and Diagnostic Science, University of Maryland Dental School, Baltimore, MD

8. Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

9. Department of Pathology, The University of Chicago, Chicago, IL

10. UC San Diego Moores Cancer Center, San Diego, CA

Funder

National Institutes of Health

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/3/250/25183731/djx186.pdf

Reference59 articles.

1. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck;Hong;N Engl J Med,1990

2. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients;Khuri;J Natl Cancer Inst,2006

3. p53 expressions: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma;Shin;J Natl Cancer Inst.,1996

4. Head and neck cancer;Vokes;N Engl J Med.,1993

5. Molecular markers of the risk of oral cancer;Lippman;N Engl J Med.,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations;Frontiers in Cell and Developmental Biology;2023-04-24

2. Unmet Needs and Perspectives in Oral Cancer Prevention;Cancers;2022-04-02

3. On the Cutting Edge of Oral Cancer Prevention: Finding Risk-Predictive Markers in Precancerous Lesions by Longitudinal Studies;Cells;2022-03-18

4. Identification of Biomarkers Associated with Cancerous Change in Oral Leukoplakia Based on Integrated Transcriptome Analysis;Journal of Oncology;2022-01-19

5. Early-Phase Interventional Trials in Oral Cancer Prevention;Cancers;2021-07-30